Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response

J Peripher Nerv Syst. 2016 Jun;21(2):114-6. doi: 10.1111/jns.12168.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous*
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins / administration & dosage*
  • Immunoglobulins, Intravenous / therapeutic use*
  • Male
  • Middle Aged
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*
  • Treatment Outcome

Substances

  • Immunoglobulins
  • Immunoglobulins, Intravenous